D. C. Angus, W. T. Linde-zwirble, J. Lidicker, G. Clermont, J. Carcillo et al., Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.1303-1310, 2001.

T. M. Balija and S. F. Lowry, Lipopolysaccharide and sepsisassociated myocardial dysfunction, Current Opinion in Infectious Diseases, vol.24, issue.3, pp.248-253, 2011.

C. B. Lorigados, F. G. Soriano, and C. Szabo, Pathomechanisms of myocardial dysfunction in sepsis, Endocrine, Metabolic & Immune Disorders Drug Targets, vol.10, issue.3, pp.274-284, 2010.

S. De-rosa, P. Cirillo, A. Paglia, L. Sasso, V. D. Palma et al., Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: Does the actual knowl, Current Vascular Pharmacology, vol.8, issue.2, pp.259-275, 2010.

F. Tamion, V. Richard, G. Bonmarchand, J. Leroy, M. Hiron et al., Reduced synthesis of inflammatory cytokines by a free radical scavenger after hemorrhagic shock in rats, Critical Care Medicine, vol.28, issue.7, pp.2522-2527, 2000.

F. Tamion, V. Richard, G. Bonmarchand, J. Leroy, J. P. Lebreton et al., Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock, American Journal of Respiratory and Critical Care Medicine, vol.164, issue.10, pp.1933-1938, 2001.

F. Tamion, V. Richard, Y. Lacoume, and C. Thuillez, Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1, American Journal of PhysiologyGastrointestinal and Liver Physiology, vol.283, issue.2, pp.408-414, 2002.

S. Leichtweis and L. L. Ji, Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress, Acta Physiologica Scandinavica, vol.172, issue.1, pp.1-10, 2001.

G. Marazzi, S. Rosanio, G. Caminiti, F. S. Dioguardi, and G. Mercuro, The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure, Current Pharmaceutical Design, vol.14, issue.25, pp.2592-2604, 2008.

C. J. Lavie, R. V. Milani, M. R. Mehra, and H. O. Ventura, Omega-3 polyunsaturated fatty acids and cardiovascular diseases, Journal of the American College of Cardiology, vol.54, issue.7, pp.585-594, 2009.

J. M. Martin and R. D. Stapleton, Omega-3 fatty acids in critical illness, Nutrition Reviews, vol.68, issue.9, pp.531-541, 2010.

K. Arab, A. Rossary, F. Flourie, Y. Tourneur, and J. P. Steghens, Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase, British Journal of Nutrition, vol.95, issue.1, pp.18-26, 2006.

F. Tamion, V. Richard, S. Lyoumi, M. Daveau, G. Bonmarchand et al., Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock, American Journal of Physiology, vol.273, issue.2, pp.314-321, 1997.

K. Uehara, T. Takahashi, H. Fujii, H. Shimizu, E. Omori et al., The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury, Critical Care Medicine, vol.33, issue.2, pp.381-390, 2005.

A. Ibrahim, K. Mbodji, A. Hassan, M. Aziz, N. Boukhettala et al., Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium, Clinical Nutrition, vol.30, issue.5, pp.678-87, 2011.

A. Hassan, A. Ibrahim, K. Mbodji, M. Coeffier, F. Ziegler et al., An alpha-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-kappaB in rats with TNBS-induced colitis, Journal of Nutrition, vol.140, issue.10, pp.1714-1721, 2010.

M. Mardones, R. Valenzuela, P. Romanque, N. Covarrubias, F. Anghileri et al., Prevention of liver ischemia reperfusion injury by a combined thyroid hormone and fish oil protocol, The Journal of Nutritional Biochemistry, vol.23, issue.9, pp.1113-1133, 2012.

R. Demiralay, N. Gursan, and H. Erdem, Regulation of sepsis-induced apoptosis of pulmonary cells by posttreatment of erdosteine and N-aceylcysteine, Toxicology, vol.228, issue.2-3, pp.151-161, 2006.

I. Sukhotnik, N. Slijper, Y. Pollak, E. Chemodanov, R. Shaoul et al., Parenteral omega-3 fatty acids (Omegaven) modulate intestinal recovery after intestinal ischemia-reperfusion in a rat model, Journal of Pediatric Surgery, vol.46, issue.7, pp.1353-1360, 2011.

P. Mulder, S. Barbier, A. Chagraoui, V. Richard, J. P. Henry et al., Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, issue.13, pp.1674-1679, 2004.

P. Mulder, V. Richard, G. Derumeaux, M. Hogie, J. P. Henry et al., Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling, Circulation, vol.96, issue.6, pp.1976-1982, 1997.

F. Moritz, C. Monteil, P. Mulder, G. Derumeaux, C. Bizet et al., Prolonged cardiac dysfunction after withdrawal of chronic cocaine exposure in rats, Journal of Cardiovascular Pharmacology, vol.42, issue.5, pp.642-647, 2003.

M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, pp.248-254, 1976.

M. Coeffier, R. Gloro, N. Boukhettala, M. Aziz, S. Lecleire et al., Increased proteasome-mediated degradation of occludin in irritable bowel syndrome, American Journal of Gastroenterology, vol.105, issue.5, pp.1181-1188, 2010.

S. Blankenberg, H. J. Rupprecht, C. Bickel, M. Torzewski, G. Hafner et al., Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease, The New England Journal of Medicine, vol.349, issue.17, pp.1605-1613, 2003.

T. Shiomi, H. Tsutsui, H. Matsusaka, K. Murakami, S. Hayashidani et al., Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice, Circulation, vol.109, issue.4, pp.544-549, 2004.

B. Liu and Y. A. Hannun, Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione, Journal of Biological Chemistry, vol.272, issue.26, pp.16281-16287, 1997.

A. Amadou, A. Nawrocki, M. Best-belpomme, C. Pavoine, and F. Pecker, Arachidonic acid mediates dual effect of TNF-alpha on Ca 2+ transients and contraction of adult rat cardiomyocytes, American Journal of Physiology. Cell Physiology, vol.282, issue.6, pp.1339-1347, 2002.

M. Cailleret, A. Amadou, N. Andrieu-abadie, A. Nawrocki, C. Adamy et al., N-acetylcysteine prevents the deleterious effect of tumor necrosis factor-(alpha) on calcium transients and contraction in adult rat cardiomyocytes, Circulation, vol.109, issue.3, pp.406-411, 2004.

M. C. Atkinson, The use of N-acetylcysteine in intensive care, Critical Care and Resuscitation, vol.4, issue.1, pp.21-27, 2002.

Y. Fang, J. Favre, M. Vercauteren, B. Laillet, I. Remy-jouet et al., Reduced cardiac remodelling and prevention of glutathione deficiency after omega-3 supplementation in chronic heart failure, Fundamental and Clinical Pharmacology, vol.25, issue.3, pp.323-332, 2011.

T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negresalvayre et al., Sphingolipid mediators in cardiovascular cell biology and pathology, Circulation Research, vol.89, issue.11, pp.957-968, 2001.

F. J. Staal, M. Roederer, and L. A. Herzenberg, Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus, Proceedings of the National Academy of Sciences of the United States of America, vol.87, issue.24, pp.9943-9947, 1990.

S. Von-haehling, E. A. Jankowska, and S. D. Anker, Tumour necrosis factor-alpha and the failing heart-pathophysiology and therapeutic implications, Basic Research in Cardiology, vol.99, issue.1, pp.18-28, 2004.

L. L. Teng, L. Shao, Y. T. Zhao, X. Yu, D. F. Zhang et al., The beneficial effect of n-3 polyunsaturated fatty acids on doxorubicin-induced chronic heart failure in rats, The Journal of International Medical Research, vol.38, issue.3, pp.940-948, 2010.

S. W. Ryter and A. M. Choi, Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models, Antioxidants & Redox Signaling, vol.7, issue.1-2, pp.80-91, 2005.

J. Alam and J. L. Cook, Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway, Current Pharmaceutical Design, vol.9, issue.30, pp.2499-2511, 2003.

M. A. Perrella and S. F. Yet, Role of heme oxygenase-1 in cardiovascular function, Current Pharmaceutical Design, vol.9, issue.30, pp.2479-2487, 2003.

L. E. Otterbein and A. M. Choi, Heme oxygenase: colors of defense against cellular stress, American Journal of Physiology. Lung Cellular and Molecular Physiology, vol.279, issue.6, pp.1029-1037, 2000.

L. E. Otterbein, M. P. Soares, K. Yamashita, and F. H. Bach, Heme oxygenase-1: unleashing the protective properties of heme, Trends in Immunology, vol.24, issue.8, pp.449-455, 2003.

F. Tamion, F. Bauer, V. Richard, K. Laude, S. Renet et al., Myocardial dysfunction in early state of endotoxemia role of heme-oxygenase-1, Journal of Surgical Research, vol.158, issue.1, pp.94-103, 2010.

P. Wiesel, A. P. Patel, N. Difonzo, P. B. Marria, C. U. Sim et al., Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice, Circulation, vol.102, issue.24, pp.3015-3022, 2000.

M. Overhaus, B. A. Moore, J. E. Barbato, F. F. Behrendt, J. G. Doering et al., Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators, American Journal of PhysiologyGastrointestinal and Liver Physiology, vol.290, issue.4, pp.695-703, 2006.

J. K. Sarady-andrews, F. Liu, D. Gallo, A. Nakao, M. Overhaus et al., Biliverdin administration protects against endotoxin-induced acute lung injury in rats, American Journal of Physiology. Lung Cellular and Molecular Physiology, vol.289, issue.6, pp.1131-1137, 2005.